Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining

Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining

Traditional drug development for Alzheimer’s disease (AD) is costly, time consuming and burdened by a very low success rate. An alternative strategy is drug repositioning, redirecting existing drugs for another disease. The large amount of biological data accumulated to date warrants a comprehensive...

Full description

Bibliographic Details
Main Authors: Zhang, Ming, Schmitt-Ulms, Gerold, Sato, Christine, Xi, Zhengrui, Zhang, Yalun, Zhou, Ye, St George-Hyslop, Peter, Rogaeva, Ekaterina
Format: Online
Language:English
Published: Public Library of Science 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179106/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179106/

Similar Items